COVID-19 Screening Strategy Comparisons
To safely expand international air travel, a data-driven, risk-based approach is necessary when assessing the appropriate passenger screening protocols for cross-border travel. As part of Boeing’s efforts to combat the COVID-19 pandemic, an analysis of passenger screening methods was conducted to minimize disease translocation risks from travel between countries. The modeling provides governments, regulatory bodies and medical experts with validated findings to help inform decisions on safe travel around the world.
This paper describes the results of a Monte Carlo simulation-based analysis comparing the efficacy of several different passenger screening strategies for air travel between countries with various COVID-19 prevalence levels. Each screening strategy is based on one or more COVID-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests conducted at varying time points and compared to a 14-day quarantine with varying levels of compliance and no testing. This work is part of Boeing’s Confident Travel Initiative, a global effort to provide passengers and crew a safe, healthy and efficient travel experience.